ORIGINAL ARTICLE
Year : 2021  |  Volume : 20  |  Issue : 3  |  Page : 232-241

Effects of soy isoflavone on cardiac dysfunction in geripause-like rats: comparisons with hormone-replacement therapy


Department of Hormone Evaluation, National Organization for Drug Control and Research, Giza, Egypt

Correspondence Address:
Marwa M Abd-Rabo
MSc Biochemistry; Department of Hormone, National Organization for Drug Control and Research, Abo-Hazem Street, P.O. Box 12553, Harram, Giza
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/epj.epj_25_21

Rights and Permissions

Background Cardiovascular diseases are a primary cause of morbidity and mortality worldwide. The prevalence of cardiovascular disease as well as inflammation in postmenopausal women is higher than premenopausal women. Objective The present study investigated cardiac dysfunction elicited by estrogen deprivation and aging and assessed a possible beneficial impact of isoflavones compared with estradiol-replacement therapy. Materials and methods Forty aged female rats were equally divided into four groups. Except for sham-operated animals in group 1 (negative control), all other rats were ovariectomized. One month after surgery, animals were assigned to groups 3 and 4. Rats in the former group were treated with 17β-estradiol, 100 μg/kg, intramuscular, every other day. Animals in group 4 were administered soy isoflavones (SIF), 40 mg/kg/day orally. Treatments continued for 1 month. Results and conclusion Compared with control rats, ovariectomized animals showed cardiac dysfunction and inflammation evidenced by dyslipidemia and elevated serum creatine phosphokinase and lactate dehydrogenase activity, angiotensin II, cardiac malondialdehyde and nitric oxide levels, and serum tumor necrosis factor-α and interleukin-6 levels. These impacts were concurrent with significant decreases in cardiac catalase activity and total antioxidant capacity. Treatment with SIF was more effective in mitigating inflammation and cardiac dysfunction compared with estradiol-replacement therapy. Histopathological examination of heart tissues supports these biochemical findings. SIF are a safe and well-tolerated alternative to estradiol for improving cardiac dysfunction elicited by menopause and age.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed818    
    Printed5    
    Emailed0    
    PDF Downloaded66    
    Comments [Add]    

Recommend this journal